Birch Biosciences Analysis: $2M Raised
What is Birch Biosciences?
Birch Biosciences develops enzyme-based plastic recycling technology for PET, polyester textiles, bottles, and clamshells. The company combines artificial intelligence, next-generation enzyme screening, and green chemistry to break plastics into monomers and remanufacture 100% recycled resin. It is based in Portland, Oregon, and says its process can match virgin PET performance while reducing emissions by more than 70%.
Location
4023 NE Hancock St, Portland, Oregon 97212, United States
Employees
1-10
Founded
2021
Revenue
$1.2M
Business Model
Revenue from grants and partnerships in plastic recycling technology development.
Product Features & Capabilities
- Engineered enzymes for plastic recycling, high-performance enzymes for breaking down plastic polymers, proprietary recycling process, enables manufacture of economical, 100% recycled plastic products, low greenhouse gas emissions, competitive pricing for recycled plastics.
How much Birch Biosciences raised
Grant - II - $1.64M
April 3, 2023Lead Investor: U.S. Department of Energy
Who are the founders of Birch Biosciences
Market Focus
Birch Biosciences primarily focuses on the biotechnology industry, specifically in the area of plastic recycling through the development of engineered enzymes for creating 100% recycled plastic products.
Competitors Overview
Birch Biosciences operates in the market of engineered enzymes for plastic recycling, where its main competitors include:
-
SEQUANA: This company focuses on using AI to design enzymes capable of breaking down plastics and plastic-based textiles. Their approach emphasizes the use of advanced technology to enhance enzyme efficiency, which may provide a competitive edge in terms of innovation and effectiveness in recycling processes.
-
Organica Biotech: Although specific details about their enzyme technology were not found, Organica Biotech is known for its work in biotechnological solutions for waste management, including plastic recycling. Their established presence in the market and experience in bioprocessing could be seen as advantages.
-
Envirobe: Similar to Organica, specific information on Envirobe's technology was not retrieved, but they are recognized for their contributions to sustainable waste management solutions. Their focus on environmental sustainability aligns with the goals of Birch Biosciences, but their specific advantages or technologies remain unclear.
Notable differences may include SEQUANA's strong emphasis on AI-driven enzyme design, which could lead to more efficient recycling processes compared to traditional methods. In contrast, Birch Biosciences leverages generative AI and advanced enzyme engineering, potentially offering unique solutions in the circular economy of plastics.
Investors
- Y Combinator
- Pegasus Tech Ventures
- Climate Capital
- US Department of Energy
- Pioneer Fund
- NextCycle Washington
- Elevate Capital
- Fundament
- Liquid 2
See something that needs updating? Suggest edits to this profile.